Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease.

Articles >
Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease.

Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease.

Javier Villadiego, Roberto García-Swinburn, Diego García-González, Rafael Lebrón-Galán, Verónica Murcia-Belmonte, Ernesto García-Roldán, Nela Suárez-Luna, Cristina Nombela, Miguel Marchena, Fernando de Castro & Juan José Toledo-Aral

Magazine Brain Struct Funct.

Year 2023

Vol: Pages(start-end) 228: 907–920

DOI https://doi.org/10.1007/s00429-023-02631-0

Research Groups

Generation and Regeneration of Bilateral Neural Circuits

Extracellular matrix protein anosmin-1 overexpression alters dopaminergic phenotype in the CNS and the PNS with no pathogenic consequences in a MPTP model of Parkinson’s disease.

Research Groups

Login